Controlled release polyurea microcapsules can be prepared from a combination of polyisocyanates using emulsion polymerization. Encapsulated catalysts prepared using the polyurea microcapsules can be used to control the cure rate of coatings and sealants.

A composition comprises a polyol and a polyethylenimine compound. A method for reducing the volatile aldehyde content of a polyol comprises the steps of: (a) providing a polyol, the polyol containing a first amount of volatile aldehyde compounds; (b) providing a polyethylenimine compound; and (c) adding the polyethylenimine compound to the polyol to produce a composition.

Polyol blends are disclosed that include a saccharide-initiated polyether polyol, an aromatic polyester polyol, and a polyalkylene polyamine-initiated polyether polyol. Also disclosed are foam-forming compositions containing such polyol blends, rigid foams made using such polyurethane foam-forming compositions, and methods for producing such foams, including use of such foams as panel insulation.

The instant invention relates to a process for the encapsulation of a non-amine hydrophilic compound C, comprising the steps of: (E1) providing a reverse emulsion containing: an oil phase (O), comprising a curable mixture of isocyanate and polyalkyldiene hydroxylated or polyol dispersed in said oil phase, drops of an aqueous phase W.sup.1, containing: said non-amine hydrophilic compound C; and at least 5% by weight of a compound C carrying more than 2 amine groups; (E2) pouring the reverse emulsion of step (E1) in a second water phase W.sup.2 to make a multiple emulsion water/oil/water; and, then, (E3) curing into polyurethane all or part of the curable mixture contained in the oil phase.

Provided are polymers (e.g., polymeric materials), nanoparticles comprising one or more of the polymers, and compositions. A polymer may be in the form of a nanoparticle. A polymer can be linear or branched. A polymer includes one or more poly(ester urea) segment, optionally, one or more poly(urethane) segment, optionally, one or more diol segment, optionally, one or more poly(ethylene glycol) segment, and, optionally, one or more terminal/end group. A polymer (e.g., a polymeric material) may include a branching moiety. For example, a composition includes one or more polymer. In an example, polymers and nanoparticles can be used to deliver a drug (e.g., gambogic acid) to an individual (e.g, who has been diagnosed with or is suspected of having cancer and/or a viral infection).

Controlled release polyurea microcapsules can be prepared from a combination of polyisocyanates using emulsion polymerization. Encapsulated catalysts prepared using the polyurea microcapsules can be used to control the cure rate of coatings and sealants.

Each of monodisperse spherical microcapsules for seeding a transparent fluid to track movements of the fluid both in translational and rotational directions comprises a core; a shell; and 1 to 5 light reflecting solid integral particles. Each of the particles reflects incoming light in a defined direction; and each of the particles is embedded in the core and fixed in its orientation with regard to the shell. The shell and the core are transparent for the incoming light to be reflected by the particles entering and exiting the microcapsule. The shell has a thickness of not more than , being a wavelength of the incoming light, so that the shell does essentially not deflect the incoming light entering and exiting the microcapsule. The core includes a main component of the fluid such that a refraction index of the core essentially matches a refraction index of the fluid.

Provided herein are polymers of Formula (I), and pharmaceutically acceptable salts, co-crystals, tautomers, stereoisomers, and isotopically labeled derivatives thereof, compositions, and formulations thereof. The polymers described herein are biocompatible, non-toxic, water compatible, and operationally simple to formulate. Also provided are methods and kits involving the polymers described herein (e.g., methods of using polymers described herein for delivering agents (e.g., for therapeutic, diagnostic, prophylactic, imaging, ophthalmic, intraoperative, or cosmetic use) to a subject, cell, tissue, or biological sample, as part of materials (e.g., biodegradable materials, biocompatible materials, wound dressing (e.g., bandages), drug depots, coatings), or as scaffolds for tissue engineering. Provided are methods for synthesizing the polymers described herein, and polymers described herein synthesized by the synthetic methods described herein.

##STR00001##

Provided herein are systems and methods for forming a polymeric object. The systems and methods can use monomers having a first type of functional group that is capable of polymerizing upon exposure to radiation and a second type of functional group that is capable of polymerizing at a second condition. The monomers can be polymerized such that the polymeric object has a first and a second network of linkages.

Spherical microcapsules including light reflecting solid integral particles reflecting incoming light in a defined direction for determining the position and orientation of the microcapsule are produced by preparing a first liquid phase containing a first polymerization partner; preparing a second liquid phase containing a second polymerization partner, the first liquid phase not being soluble in the second liquid phase, and the second polymerization partner being configured to polymerize with the first polymerization partner under polymerization conditions; dispersing the solid particles in the first liquid phase; forming droplets of the first liquid phase including at least one solid particle; and immersing the droplets in the second liquid phase under the polymerization conditions. The first polymerization partner and the second polymerization partner polymerize at the surfaces of the droplets forming shells of a polymeric material enclosing the individual droplets, and the light reflecting solid integral particles are fixed to the shells.